{"id":183501,"date":"2026-08-05T16:01:32","date_gmt":"2026-08-05T10:31:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=183501"},"modified":"2026-08-05T16:01:35","modified_gmt":"2026-08-05T10:31:35","slug":"themis-medicare-share-price-outlook-next-3-years","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/","title":{"rendered":"Where Will Themis Medicare Share Price Be in the Next 3 Years?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Themis Medicare share price Rs 111. 52W high Rs 148, low Rs 65. Market cap Rs 1,050 Cr. 2030 scenario range Rs 62.4 to Rs 361.<\/em><\/p>\n<p>The Themis Medicare share price outlook for the next 3 years is a question on many investors&#8217; minds as the stock trades at Rs 111, within a 52 week range of Rs 65 to Rs 148. This article lays out a scenario based Themis Medicare share price outlook for 2027, 2028 and 2030, built on the company&#8217;s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=themis-medicare-outlook-3yr\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Themis_Medicare_Company_Overview\" title=\"Themis Medicare Company Overview\">Themis Medicare Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Where_Does_Themis_Medicare_Share_Price_Stand_Today\" title=\"Where Does Themis Medicare Share Price Stand Today?\">Where Does Themis Medicare Share Price Stand Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Themis_Medicare_Share_Price_Outlook_Key_Growth_Drivers_for_the_Next_3_Years\" title=\"Themis Medicare Share Price Outlook: Key Growth Drivers for the Next 3 Years\">Themis Medicare Share Price Outlook: Key Growth Drivers for the Next 3 Years<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Capacity_Expansion_and_Product_Approvals\" title=\"Capacity Expansion and Product Approvals\">Capacity Expansion and Product Approvals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Healthcare_and_Life_Sciences_Demand\" title=\"Healthcare and Life Sciences Demand\">Healthcare and Life Sciences Demand<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Company_Specific_Catalysts\" title=\"Company Specific Catalysts\">Company Specific Catalysts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Macro_Environment_and_Liquidity\" title=\"Macro Environment and Liquidity\">Macro Environment and Liquidity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Themis_Medicare_Share_Price_Outlook_2027_2028_and_2030_Scenario_Analysis\" title=\"Themis Medicare Share Price Outlook 2027, 2028 and 2030: Scenario Analysis\">Themis Medicare Share Price Outlook 2027, 2028 and 2030: Scenario Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Bull_Case_vs_Bear_Case_for_Themis_Medicare_Share_Price\" title=\"Bull Case vs Bear Case for Themis Medicare Share Price\">Bull Case vs Bear Case for Themis Medicare Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#The_Bull_Case\" title=\"The Bull Case\">The Bull Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#The_Bear_Case\" title=\"The Bear Case\">The Bear Case<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Key_Risks_That_Could_Change_the_Themis_Medicare_Share_Price_Outlook\" title=\"Key Risks That Could Change the Themis Medicare Share Price Outlook\">Key Risks That Could Change the Themis Medicare Share Price Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Is_Themis_Medicare_Worth_Watching_for_the_Long_Term\" title=\"Is Themis Medicare Worth Watching for the Long Term?\">Is Themis Medicare Worth Watching for the Long Term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#FAQs_on_Themis_Medicare_Share_Price_Outlook\" title=\"FAQs on Themis Medicare Share Price Outlook\">FAQs on Themis Medicare Share Price Outlook<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_is_the_Themis_Medicare_share_price_outlook_for_the_next_3_years\" title=\"What is the Themis Medicare share price outlook for the next 3 years?\">What is the Themis Medicare share price outlook for the next 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_is_the_future_of_Themis_Medicare_share_price\" title=\"What is the future of Themis Medicare share price?\">What is the future of Themis Medicare share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_is_the_Themis_Medicare_share_price_outlook_for_2027\" title=\"What is the Themis Medicare share price outlook for 2027?\">What is the Themis Medicare share price outlook for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_is_the_Themis_Medicare_share_price_projection_for_2030\" title=\"What is the Themis Medicare share price projection for 2030?\">What is the Themis Medicare share price projection for 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_is_the_current_share_price_of_Themis_Medicare\" title=\"What is the current share price of Themis Medicare?\">What is the current share price of Themis Medicare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#Is_Themis_Medicare_a_good_stock_for_the_long_term\" title=\"Is Themis Medicare a good stock for the long term?\">Is Themis Medicare a good stock for the long term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-outlook-next-3-years\/#What_are_the_key_risks_to_the_Themis_Medicare_share_price_outlook\" title=\"What are the key risks to the Themis Medicare share price outlook?\">What are the key risks to the Themis Medicare share price outlook?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Themis_Medicare_Company_Overview\"><\/span><strong>Themis Medicare Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Themis Medicare is a pharmaceutical manufacturer of antiseptic, anti-tuberculosis, anti-malarial and pain management drugs along with synthetic bulk drugs from plants in Vapi and Baroda. Understanding the business model is the first step in framing any credible Themis Medicare share price outlook, because the durability of earnings ultimately decides where the stock trades.<\/p>\n<table>\n<tbody>\n<tr>\n<td><strong>Company<\/strong><\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/themismed\/themis-medicare-ltd-share-price-today\">Themis Medicare<\/a><\/td>\n<\/tr>\n<tr>\n<td><strong>NSE Ticker<\/strong><\/td>\n<td>THEMISMED<\/td>\n<\/tr>\n<tr>\n<td><strong>Sector<\/strong><\/td>\n<td>Formulations and Active Pharmaceutical Ingredients<\/td>\n<\/tr>\n<tr>\n<td><strong>CMP<\/strong><\/td>\n<td>Rs 111<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week High<\/strong><\/td>\n<td>Rs 148<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week Low<\/strong><\/td>\n<td>Rs 65<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap<\/strong><\/td>\n<td>Rs 1,050 Cr<\/td>\n<\/tr>\n<tr>\n<td><strong>Dividend Yield<\/strong><\/td>\n<td>0.44%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Where_Does_Themis_Medicare_Share_Price_Stand_Today\"><\/span><strong>Where Does Themis Medicare Share Price Stand Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock currently trades about 25 percent below its 52 week high of Rs 148, which means the market has already priced in some caution. For anyone building a Themis Medicare share price outlook, this starting point matters, because entry valuations have a large bearing on 3 year returns.<\/p>\n<p>At the current price, Themis Medicare commands a market capitalisation of Rs 1,050 Cr. These figures anchor the Themis Medicare share price outlook scenarios that follow. How the broader <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> index trades over this period will also influence the multiple investors are willing to assign to the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Outlook_Key_Growth_Drivers_for_the_Next_3_Years\"><\/span><strong>Themis Medicare Share Price Outlook: Key Growth Drivers for the Next 3 Years<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A handful of forces are likely to shape the Themis Medicare share price outlook between now and 2030, and together they explain most of the dispersion in this Themis Medicare share price outlook. Each is discussed below with its likely direction of impact.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Capacity_Expansion_and_Product_Approvals\"><\/span><strong>Capacity Expansion and Product Approvals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Stock prices ultimately follow earnings. Anti-tuberculosis products have historically accounted for a majority of the company&#8217;s turnover, giving it a defined therapeutic niche. The pace at which this plays out over FY27 to FY30 will be one of the biggest determinants of the Themis Medicare share price outlook actually materialising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Healthcare_and_Life_Sciences_Demand\"><\/span><strong>Healthcare and Life Sciences Demand<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Themis Medicare operates in the formulations and active pharmaceutical ingredients space, where sector-wide demand and pricing cycles influence how investors value the stock. Structural tailwinds in this segment, if sustained, support the more optimistic end of the Themis Medicare share price outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Company_Specific_Catalysts\"><\/span><strong>Company Specific Catalysts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A recovery in formulation sales volumes and better utilisation at its API plants are the key near term drivers. If this plays out on schedule, the Themis Medicare share price outlook for 2030 could gravitate toward the upper end of the scenario range discussed below.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Macro_Environment_and_Liquidity\"><\/span><strong>Macro Environment and Liquidity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay for Themis Medicare. A benign macro backdrop supports the optimistic end of this Themis Medicare share price outlook, while global risk aversion would do the opposite.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Outlook_2027_2028_and_2030_Scenario_Analysis\"><\/span><strong>Themis Medicare Share Price Outlook 2027, 2028 and 2030: Scenario Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below presents a scenario based Themis Medicare share price outlook using compounded growth assumptions applied to the current market price of Rs 111. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Year<\/th>\n<th>Bear Case<\/th>\n<th>Base Case<\/th>\n<th>Bull Case<\/th>\n<th>Assumption<\/th>\n<\/tr>\n<tr>\n<td>2027<\/td>\n<td>Rs 91.6<\/td>\n<td>Rs 121<\/td>\n<td>Rs 165<\/td>\n<td>-12% to 30% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>Rs 80.6<\/td>\n<td>Rs 128<\/td>\n<td>Rs 214<\/td>\n<td>-12% to 30% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>Rs 62.4<\/td>\n<td>Rs 144<\/td>\n<td>Rs 361<\/td>\n<td>-12% to 30% CAGR on CMP<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the base case scenario of this Themis Medicare share price outlook, the 2030 level works out to roughly Rs 144, implying steady compounding from today&#8217;s levels. The bull case of Rs 361 plays out if a recovery in formulation sales volumes and better utilisation at its API plants are the key near term drivers, which would let both earnings and the valuation multiple re-rate higher, while the bear case of Rs 62.4 captures a scenario where growth stalls. That is an outcome band of about -44 percent to 225 percent over the period.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Consult a SEBI Registered Investment Advisor Before Acting on Any Projection<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_vs_Bear_Case_for_Themis_Medicare_Share_Price\"><\/span><strong>Bull Case vs Bear Case for Themis Medicare Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"The_Bull_Case\"><\/span><strong>The Bull Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The optimistic Themis Medicare share price outlook assumes a recovery in formulation sales volumes and better utilisation at its API plants are the key near term drivers. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 361 by 2030.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"The_Bear_Case\"><\/span><strong>The Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The cautious view centres on the fact that recent quarters have swung to losses on declining sales, so a turnaround in the core formulations business still needs to be demonstrated. If these pressures dominate, the Themis Medicare share price outlook would skew toward the lower band and the stock could stagnate near Rs 62.4 even by 2030, underperforming broader indices.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Change_the_Themis_Medicare_Share_Price_Outlook\"><\/span><strong>Key Risks That Could Change the Themis Medicare Share Price Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution risk:<\/strong> Delays in scaling operations, branch or capacity expansion, or new business lines could push the earnings trajectory below the base case.<\/li>\n<li><strong>Valuation risk:<\/strong> At the current earnings multiple, any disappointment on profit growth can trigger sharp multiple compression before fundamentals stabilise.<\/li>\n<li><strong>Sector risk:<\/strong> Recent quarters have swung to losses on declining sales, so a turnaround in the core formulations business still needs to be demonstrated.<\/li>\n<li><strong>Macro risk:<\/strong> A global or domestic slowdown, adverse FII flows or unexpected rate moves would compress equity valuations broadly, including for this stock.<\/li>\n<li><strong>Regulatory risk:<\/strong> Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little advance warning.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Is_Themis_Medicare_Worth_Watching_for_the_Long_Term\"><\/span><strong>Is Themis Medicare Worth Watching for the Long Term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>For long term investors, the relevant question is not just where the Themis Medicare share price outlook lands in 2030 or what any single Themis Medicare share price outlook says today, but whether the business can compound capital through cycles. Anti-tuberculosis products have historically accounted for a majority of the company&#8217;s turnover, giving it a defined therapeutic niche. That gives Themis Medicare a credible story to track, while the risks outlined above define what must be monitored each quarter.<\/p>\n<p>Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Themis Medicare share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Themis Medicare share price live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Themis Medicare share price outlook for the next 3 years spans Rs 62.4 to Rs 361 by 2030 under the scenarios discussed, with a base case near Rs 144. Any credible Themis Medicare share price outlook must be updated as facts change, and the path will be decided by earnings delivery, sector conditions and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Themis_Medicare_Share_Price_Outlook\"><\/span><strong>FAQs on Themis Medicare Share Price Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_outlook_for_the_next_3_years\"><\/span><strong>What is the Themis Medicare share price outlook for the next 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Themis Medicare share price outlook for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 62.4 in the bear case to Rs 361 in the bull case, with a base case near Rs 144, depending on earnings delivery and market conditions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_future_of_Themis_Medicare_share_price\"><\/span><strong>What is the future of Themis Medicare share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The future of Themis Medicare share price depends largely on how the company executes against its growth drivers over FY27 to FY30, alongside sector conditions and the broader market environment. Historically, businesses that deliver consistent earnings tend to see steadier price outcomes over such horizons.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_outlook_for_2027\"><\/span><strong>What is the Themis Medicare share price outlook for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> For 2027, the scenario range works out to roughly Rs 91.6 to Rs 165, with a base case around Rs 121. This is illustrative and not a guaranteed outcome, and actual prices will depend on quarterly results and market sentiment.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_projection_for_2030\"><\/span><strong>What is the Themis Medicare share price projection for 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Themis Medicare share price projection for 2030 spans Rs 62.4 to Rs 361 across the bear and bull scenarios discussed in this article, with the base case near Rs 144. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Themis_Medicare\"><\/span><strong>What is the current share price of Themis Medicare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Themis Medicare currently trades at around Rs 111 on the NSE, within a 52 week range of Rs 65 to Rs 148. Prices change continuously during market hours, so check live quotes before acting.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Themis_Medicare_a_good_stock_for_the_long_term\"><\/span><strong>Is Themis Medicare a good stock for the long term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Themis Medicare has a growth story worth watching: anti-tuberculosis products have historically accounted for a majority of the company&#8217;s turnover, giving it a defined therapeutic niche. At the same time it carries risks, since recent quarters have swung to losses on declining sales, so a turnaround in the core formulations business still needs to be demonstrated. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Themis_Medicare_share_price_outlook\"><\/span><strong>What are the key risks to the Themis Medicare share price outlook?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are execution delays, valuation compression if earnings disappoint, sector-specific pressures, macro shocks such as adverse FII flows or rate moves, and regulatory or policy changes. Any of these can push the stock below the base case scenario discussed in this article.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Where will Themis Medicare share price be in the next 3 years? Detailed Themis Medicare share price outlook with 2027, 2028 and 2030 scenarios, growth drivers, risks and bull vs bear view. August 2026.<\/p>\n","protected":false},"author":28,"featured_media":183500,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-183501","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["183500"],"_edit_lock":["1785925897:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_title":["Themis Medicare Share Price Outlook: Where It Could Be in 3 Years"],"rank_math_description":["Where will Themis Medicare share price be in the next 3 years? Detailed Themis Medicare share price outlook with 2027, 2028 and 2030 scenarios, growth drivers, risks and bull vs bear view. August 2026."],"rank_math_focus_keyword":["Themis Medicare share price outlook"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-08-04"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["34156"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/themis-medicare-share-price-outlook-next-3-years.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=183501"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183501\/revisions"}],"predecessor-version":[{"id":186642,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183501\/revisions\/186642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/183500"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=183501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=183501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=183501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}